Evelo Biosciences (EVLO) Set to Post Earnings on Tuesday

Evelo Biosciences (NASDAQ:EVLO – Get Free Report) will likely be releasing its results on Tuesday, November 17th. Analysts expect Evelo Biosciences to announce earnings of ($10.1333) per share for the quarter.

Evelo Biosciences Trading Down 100.0%

The stock has a market capitalization of $2,000.00, a price-to-earnings ratio of -0.00 and a beta of 1.34. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00.

About Evelo Biosciences

(Get Free Report)

Evelo Biosciences, Inc. was a clinical-stage biotechnology company focused on developing orally administered medicines designed to modulate the immune system through the small intestinal axis. The company’s approach centered on “monoclonal microbials,” which are defined strains of bacteria intended to produce targeted effects on immune and inflammatory pathways. Evelo’s development programs included EDP1815, an investigational treatment studied in inflammatory diseases such as atopic dermatitis and psoriasis, and EDP2939, an investigational program intended to address immune-mediated conditions.

Read More

Earnings History for Evelo Biosciences (NASDAQ:EVLO)

Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.